Friday, September 17, 2021
HomeWorldRecognizing the usefulness of Russian vaccine, India's big decision

Recognizing the usefulness of Russian vaccine, India’s big decision

- Advertisement -

New Delhi: India has made a big decision by changing its strategy in the fight against the Karuna epidemic.

- Advertisement -

According to Indian media, the Drug Controller General of India (DCGI) has approved the bridging trial of the third phase of the Russian vaccine ‘Spontaneous Light’.

A recent study published in the medical journal The Legend found that Sputnik Light had a 78.6 to 83.7% effect against codeine nineteen, much higher than most two-dose vaccines. ۔

- Advertisement -

Earlier in July, the CDSCO’s subject matter expert committee ruled out the need for third-stage testing of Russian vaccines across the country and refused to authorize Sputnik-Light for emergency use.

The committee noted that the Sputnik-Light Sputnik-V elements were identical and that its security and immunogenicity data in the Indian population had already been prepared in a test.

- Advertisement -

Also read: Russia has also approved a single dose of the Sputnik vaccine

A recent study of at least 40,000 elderly people in Argentina found that Sputnik Light reduced hospital admissions among the target population from 82.1% to 87.6%.

The Russian Direct Investment Fund (RDIF) last year partnered with Dr. Reddy’s Laboratories for the third phase trial of the Sputnik-V vaccine in India. In April, Sputnik-V received an emergency use authority in India. Was

Comments

- Advertisement -
RELATED ARTICLES
- Advertisment -

Most Popular